Share chart Ginkgo Bioworks Holdings, Inc.
Extended chart
Simple chart
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. разрабатывает платформу для клеточного программирования. Его платформа используется для программирования клеток для обеспечения биологического производства продуктов, таких как новые терапевтические препараты, пищевые ингредиенты и химические вещества, полученные из нефти. Компания обслуживает различные конечные рынки, включая специализированные химические продукты, сельское хозяйство, продукты питания, потребительские товары и фармацевтику. Ginkgo Bioworks Holdings, Inc. была основана в 2008 году и базируется в Бостоне, штат Массачусетс.IPO date | 2021-04-19 |
---|---|
ISIN | US37611X1000 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | https://www.ginkgobioworks.com |
Цена ао | 6.64 |
Change price per day: | -6.74% (7.12) |
---|---|
Change price per week: | -11.23% (7.48) |
Change price per month: | -36.52% (10.46) |
Change price per 3 month: | -29.14% (9.37) |
Change price per half year: | -13.77% (7.7) |
Change price per year: | -84.49% (42.8) |
Change price per 3 year: | +95.29% (3.4) |
Change price per year to date: | -29.14% (9.37) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Baillie Gifford and Company | 233 | 13.63 |
ARK Investment Management, LLC | 190 | 11.09 |
Viking Global Investors, L.P. | 143 | 8.37 |
Vanguard Group Inc | 126 | 7.36 |
Blackrock Inc. | 73 | 4.26 |
Anchorage Capital Group, LLC | 70 | 4.09 |
Sumitomo Mitsui Trust Holdings, Inc. | 56 | 3.27 |
Nikko Asset Management Americas, Inc. | 56 | 3.27 |
Morgan Stanley | 49 | 2.87 |
State Street Corporation | 27 | 1.56 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
De-Spac ETF | 5.53 | 0 | 0.09 |
AXS Cannabis ETF | 1.2 | 1.95 | 2.89 |
iShares Morningstar Small-Cap Growth ETF | 0.00801 | 33.63 | 0.72598 |
iShares Morningstar Small-Cap Growth ETF | 0.00801 | 587.89 | 0.72598 |
iShares Morningstar Small-Cap ETF | 0.00654 | 30.1 | 1.60498 |
iShares Morningstar Small-Cap ETF | 0.00654 | 391.25 | 1.60498 |
iShares Morningstar Small Cap Value ETF | 0.00562 | 26.7 | 2.50476 |
iShares Morningstar Small-Cap Value ETF | 0.00562 | 201.65 | 2.50476 |
iShares U.S. Tech Breakthrough Multisector ETF | 0.00511 | 21.8 | 0.73986 |
![]() |
0 | 23.54 | 1.26927 |
0.68 | 131.85 | 1.47 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Jason Kelly | Founder, CEO & Director | 262.5k | 1981 (44 years) |
Dr. Reshma P. Shetty | Founder, President, COO & Director | 262.5k | 1981 (44 years) |
Mr. Mark E. Dmytruk | Chief Financial Officer | 465.25k | 1971 (54 years) |
Mr. Bartholomew Canton | Founder, CTO & Secretary | N/A | |
Ms. Samantha Sutton | Head of People | N/A | |
Mr. Thomas Knight Jr. | Founder | N/A | |
Karen Tepichin | General Counsel & Secretary | N/A | |
Mr. Steven P. Coen CPA | Chief Accounting Officer | N/A | |
Mr. Austin Che Ph.D. | Founder, Head of Strategy & Treasurer | ||
Ms. Anna Marie Wagner M.B.A. | Senior Vice President of Corporate Development | 1990 (35 years) |
Address: United States, Boston, MA , 27 Drydock Avenue - open in Google maps, open in Yandex maps
Website: https://www.ginkgobioworks.com
Website: https://www.ginkgobioworks.com